RE: Where are we at26 Jun 2025 13:16
Interesting point Pingu. P1 is obviously still thriving, P2 is thriving too, which is fantastic news. But how come we haven't been bought yet? Is big pharma wanting longer and even more data? Possibly a third patient, possibly even a 4th patient? Has Vlad got really greedy and wants more money than being offered? Has he even been offered anything at all? Big pharma have lots of patience and lots of money. Vlad has little time and precious little money. Anyway, it'll all come to a head very soon, definitely this year, probably around late August to September.
Incidently, looks like the last 2 trades are buys marked as sells. Nice